title: Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up.
authors.affiliation: Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030-4096, USA.
authors.forename: V A
authors.initials: VA
authors.lastname: Papadimitrakopoulou
authors.forename: W K
authors.initials: WK
authors.lastname: Hong
authors.forename: J S
authors.initials: JS
authors.lastname: Lee
authors.forename: J W
authors.initials: JW
authors.lastname: Martin
authors.forename: J J
authors.initials: JJ
authors.lastname: Lee
authors.forename: J G
authors.initials: JG
authors.lastname: Batsakis
authors.forename: S M
authors.initials: SM
authors.lastname: Lippman
mesh_terms: D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000517:prevention & control*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000517:prevention & control; D006801:Humans; D015474:Isotretinoin / Q000494:pharmacology / Q000627:therapeutic use*; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome; D019207:beta Carotene / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D016588:Anticarcinogenic Agents; D019207:beta Carotene; D015474:Isotretinoin